genedrive plc (LON:GDR – Get Free Report) traded down 4.4% on Tuesday . The stock traded as low as GBX 2.11 ($0.03) and last traded at GBX 2.15 ($0.03). 3,086,236 shares traded hands during mid-day trading, an increase of 19% from the average session volume of 2,585,487 shares. The stock had previously closed at GBX 2.25 ($0.03).
genedrive Trading Up 1.9 %
The company has a quick ratio of 5.52, a current ratio of 1.63 and a debt-to-equity ratio of 8.57. The firm has a market capitalization of £11.62 million, a price-to-earnings ratio of -53.48 and a beta of -0.04. The business has a 50-day moving average of GBX 2.25 and a two-hundred day moving average of GBX 2.50.
Insider Transactions at genedrive
In other news, insider Ian David Gilham bought 225,000 shares of the business’s stock in a transaction that occurred on Friday, December 20th. The stock was acquired at an average cost of GBX 2 ($0.02) per share, for a total transaction of £4,500 ($5,505.93). 14.75% of the stock is owned by insiders.
genedrive Company Profile
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.
Read More
- Five stocks we like better than genedrive
- What Are the FAANG Stocks and Are They Good Investments?
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Comparing and Trading High PE Ratio Stocks
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- Are Penny Stocks a Good Fit for Your Portfolio?
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.